| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/12/2012 | WO2011133039A3 Novel conjugates of cc-1065 analogs and bifunctional linkers |
| 04/12/2012 | WO2011130246A3 Compositions with reactive ingredients, and wound dressings, apparatuses, and methods |
| 04/12/2012 | WO2011127291A3 Compositions and methods for the treatment of a neoplasia |
| 04/12/2012 | WO2011098962A3 Anionic polysaccharides functionalised by at least two hydrophobic groups supported by an at least trivalent spacer |
| 04/12/2012 | WO2011083490A3 Stable veterinary composition for enhanced phosphorous uptake |
| 04/12/2012 | US20120089084 Wound healing device |
| 04/12/2012 | US20120088927 Methods for the Formation of Hydrogels Using Thiosulfonate Compositions and Uses Thereof |
| 04/12/2012 | US20120088849 Oil-adsorbing composition, method for its production, and method for using the oil-adsorbing composition |
| 04/12/2012 | US20120088848 Methods and compositions for controlled polypeptide synthesis |
| 04/12/2012 | US20120088846 Radiopaque shape-memory polymers |
| 04/12/2012 | US20120088845 Synthesis, capping and dispersion of nanocrystals |
| 04/12/2012 | US20120088844 Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains |
| 04/12/2012 | US20120088843 Polymerizable chain-extended polysiloxanes with pendant hydrophilic groups |
| 04/12/2012 | US20120088842 Methods for optimizing electroporation |
| 04/12/2012 | US20120088832 Anti-Adhesive Barrier Membrane Using Alginate and Hyaluronic Acid for Biomedical Applications |
| 04/12/2012 | US20120088824 Dosage unit comprising a prostaglandin analog for treating constipation |
| 04/12/2012 | US20120088745 Chemically modified small molecules |
| 04/12/2012 | US20120088726 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations |
| 04/12/2012 | US20120088725 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 04/12/2012 | US20120088659 Compositions and Methods for Delivery of Materials |
| 04/12/2012 | US20120087982 Extended release opioid abuse deterrent compositions and methods of making same |
| 04/12/2012 | US20120087977 Aqueous carbonated medium containing an amino(meth)acrylate polymer or copolymer |
| 04/12/2012 | US20120087975 Method of Producing A Cationic Liposomal Preparation Comprising A Lipophilic Compound |
| 04/12/2012 | US20120087959 Nanodispersion of a drug and process for its preparation |
| 04/12/2012 | US20120087957 Process for the preparation of pharmaceutical suspensions for inhalation |
| 04/12/2012 | US20120087952 Pulmonary Delivery in Treating Disorders of the Central Nervous System |
| 04/12/2012 | US20120087891 Reversible Gel-forming Compositions for Controlled Delivery of Bioactive Substances |
| 04/12/2012 | US20120087884 Novel 3.2.1-bicyclo-octene and -octane compounds |
| 04/12/2012 | US20120087874 Warming compositions and delivery systems therefor |
| 04/12/2012 | US20120087859 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties |
| 04/12/2012 | US20120087857 Gadolinium expressed lipid nanoparticles for magnetic resonance imaging |
| 04/12/2012 | DE102010042338A1 Zusammensetzung zur Behandlung von Krebs mit kontrollierter Freisetzung des Wirkstoffes A composition for treatment of cancer with controlled release of the active ingredient |
| 04/12/2012 | CA2814040A1 A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use |
| 04/12/2012 | CA2813814A1 Tumor specific antibodies and uses therefor |
| 04/12/2012 | CA2813146A1 Oral vaccine fast-dissolving dosage form using starch |
| 04/12/2012 | CA2805387A1 Environmentally sensitive compositions |
| 04/11/2012 | EP2438930A1 Prodrugs comprising an exendin linker conjugate |
| 04/11/2012 | EP2438929A2 Anti-infective solution including a compound such as pyrido(3,2,1-IJ)-benzoxadiazine |
| 04/11/2012 | EP2438926A1 Vaccine for mycoplasma infection |
| 04/11/2012 | EP2438922A1 Collagen production enhancer |
| 04/11/2012 | EP2438917A1 Transdermal preparation |
| 04/11/2012 | EP2438912A2 Plaster containing fentanyl |
| 04/11/2012 | EP2438076A1 Targetted drug delivery to the bone |
| 04/11/2012 | EP2437844A2 Rejuvenating coronary artery by improving blood flow with the help of insertion of nano-balls (encapsulated nanoparticles) containing therapeutic agents by non implantable device for tissues and thereby providing in tissue release to address the required cell cycle |
| 04/11/2012 | EP2437790A1 Conjugation methods |
| 04/11/2012 | EP2437789A1 Biomolecule-polymer conjugates and methods of making same |
| 04/11/2012 | EP2437788A1 Proteins modified with (amino)-monosaccharide-biotin adduct |
| 04/11/2012 | EP2437787A2 A virus-like particle vector for delivery of pharmaceutical agents, a process for the manufacture thereof, its uses and a pharmaceutical composition. |
| 04/11/2012 | EP2437786A1 Prodrugs containing albumin binding probe |
| 04/11/2012 | EP2437785A2 METHODS FOR IDENTIFICATION OF SITES FOR IgG CONJUGATION |
| 04/11/2012 | EP2437784A1 Alginate oligomers for use in overcoming multidrug resistance in bacteria |
| 04/11/2012 | EP2437783A1 Treatment of acinetobacter with alginate oligomers and antibiotics |
| 04/11/2012 | EP2437782A2 Stabilised composition comprising at least one adrenergic compound |
| 04/11/2012 | EP2437781A2 Stabilised composition comprising at least one adrenergic compound |
| 04/11/2012 | EP2437767A1 Molecules with extended half-lives and uses thereof |
| 04/11/2012 | EP2437736A2 Drug delivery systems |
| 04/11/2012 | EP2437735A2 Compositions and methods for delivery of materials |
| 04/11/2012 | EP2437733A1 Sustained release dosage form |
| 04/11/2012 | EP2437730A1 Buccal and/or sublingual therapeutic formulation |
| 04/11/2012 | EP2437727A2 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 04/11/2012 | EP2437723A1 Omega-3 oil containing ophthalmic emulsions |
| 04/11/2012 | EP2437653A1 Paa nanoparticles for enhancement of tumor imaging |
| 04/11/2012 | EP2437602A1 Ophthalmic formulations, methods of manufacture, and methods of using same |
| 04/11/2012 | EP2170302B1 Sustained release bionanocomposites, a process for producing the same and use thereof |
| 04/11/2012 | EP2109465B1 Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same |
| 04/11/2012 | EP1991248B1 Antidepressant prodrugs |
| 04/11/2012 | EP1683526B1 Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac |
| 04/11/2012 | EP1652517B8 Hyaluronic acid nanoparticles |
| 04/11/2012 | EP1594533B1 Antibody vaccine conjugates and uses therefor |
| 04/11/2012 | EP1492531B3 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 04/11/2012 | EP1320387B1 Pharmaceutical compositions for sustained delivery of peptides |
| 04/11/2012 | EP1282646B1 Human monoclonal antibodies to dendritic cells |
| 04/11/2012 | EP1194123B1 Method for controlled production of ultrafine microparticles and nanoparticles |
| 04/11/2012 | EP1058538B2 Fast disintegrating tablets |
| 04/11/2012 | CN1960729B 伊立替康制剂 Irinotecan preparations |
| 04/11/2012 | CN102414291A Process for producing 1-menthyl (3s)-3-hydroxybutanoate and composition for stimulating sense |
| 04/11/2012 | CN102414290A (3r)-3-羟基丁酸l-薄荷酯、其制备方法、以及包含它的感觉刺激组合物 (3r) -3- hydroxybutyrate l- menthyl, its preparation, and its sensory stimulation comprising compositions |
| 04/11/2012 | CN102413843A 干扰素α载体前药 Carrier prodrugs interferon α |
| 04/11/2012 | CN102413842A 前药 Prodrugs |
| 04/11/2012 | CN102413821A 经皮吸收型制剂 Percutaneous absorption type preparation |
| 04/11/2012 | CN102408832A 一种二氧化氯醇类溶剂漂白紫胶的方法及其应用 One kind of chlorine dioxide bleaching shellac alcohol solvent method and its application |
| 04/11/2012 | CN102408575A Preparation method of injectable polypeptide hydrogel |
| 04/11/2012 | CN102408561A 一种嵌段共聚物、其制备方法及温度敏感型水凝胶 A block copolymer, its preparation method and the temperature-sensitive hydrogels |
| 04/11/2012 | CN102408560A Preparation method of environment response type radial copolymer |
| 04/11/2012 | CN102408498A 一种透明质酸键合聚乙烯亚胺共聚物、其制备方法及应用 One kind of hyaluronic acid bonded polyethyleneimine copolymer, its preparation method and application |
| 04/11/2012 | CN102408496A 一种原位交联海藻酸钠水凝胶及其制备方法 An in-situ cross-linked alginate hydrogels and its preparation method |
| 04/11/2012 | CN102408445A Hexaminoacid ester phenoxyl cyclotriphosphazene, its fluorescent nano-microsphere and preparation method thereof |
| 04/11/2012 | CN102406950A 一种锰基核磁共振成像造影剂及其制备方法和应用 One kind of manganese-based magnetic resonance imaging contrast agent and its preparation method and application |
| 04/11/2012 | CN102406946A 高分子阿霉素键合药及其制备方法 Polymer bonding agent doxorubicin and its preparation method |
| 04/11/2012 | CN102406945A Fluorocarbon and cyclodextrin inclusion compound and preparation method thereof |
| 04/11/2012 | CN102406944A 抗ku70内化的抗体 Within the anti-ku70 antibodies |
| 04/11/2012 | CN102406943A 人成纤维细胞生长因子-21的聚乙二醇化学修饰物及其制备方法 Polyethylene glycol chemically modified human adult material fibroblast growth factor-21 and its preparation method |
| 04/11/2012 | CN102406942A 一种制备纳豆激酶环糊精包合物的方法 A process for preparing cyclodextrin inclusion of nattokinase |
| 04/11/2012 | CN102406941A 含有改性明胶肽的纳米化难溶性活性组分及其制备方法 Nano-insoluble active ingredients and preparation method of modified gelatin-containing peptides |
| 04/11/2012 | CN102406940A Application of nanoscale flaky carboxymethyl starch sodium in solid sipersion |
| 04/11/2012 | CN102406939A Method for improving solubility of slightly soluble medicine to improve bioavailability |
| 04/11/2012 | CN102406922A 兽用复方长效烟酸诺氟沙星混悬液及其制备方法 Long-acting niacin norfloxacin suspension veterinary compound and its preparation method |
| 04/11/2012 | CN102406890A 改良的组合物及其制备方法和用途 Improved composition and its preparation method and uses |
| 04/11/2012 | CN102406886A 一种治疗慢性胃炎、胃溃疡的纳米乳复方透皮喷剂 A treatment for chronic gastritis, gastric ulcer compound transdermal spray nanoemulsion |
| 04/11/2012 | CN102406827A 一种咽炎咀嚼片及成型工艺 One kind of pharyngitis chewable tablets and molding process |